Skip to main content
PFE
NYSE Life Sciences

Pfizer Lifts 2026 Outlook on Eliquis and Cancer Drug Demand, Names New CFO

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$30.73
Mkt Cap
$174.809B
52W Low
$23.62
52W High
$31.04
52W Position info
30% above low
Off High info
at 52W high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

PFE sits 30% above its 52-week low of $23.62.

Summary

Pfizer raised full-year 2026 revenue guidance to $62.0-64.0 billion from $60.5-62.5 billion and adjusted EPS to $2.95-3.05 from $2.80-3.00, citing strong demand for Eliquis and its cancer drugs. Q3 revenue of $16.58 billion beat the $15.87 billion consensus, and the new EPS midpoint of $3.00 sits above the $2.96 analysts expected. The raise matters because Pfizer is fighting patent cliffs later this decade and has been leaning on deals and licensing to refill the pipeline — better-than-expected base business buys time and credibility for that strategy. Separately, the board named Cecile Guegan CFO effective November 1, filling the seat Dave Denton vacated in August for Nike. Shares are already near a 52-week high, so the guidance hike lands into an optimistic setup rather than a beaten-down one.

At the time of this announcement, PFE was trading at $30.73 on NYSE in the Life Sciences sector, with a market capitalization of approximately $174.8B. The 52-week trading range was $23.62 to $31.04. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 18, 2026, 7:20 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.28
Real-time Price: $28.13 info
Change: -$0.150 (-0.53%) info
Market Cap: $160.593B info
PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $28.13 info
Change: -$0.990 (-3%) info
Market Cap: $160.593B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $28.13 info
Change: -$0.7225 (-3%) info
Market Cap: $160.593B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $28.13 info
Change: -$1.32 (-4%) info
Market Cap: $160.593B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $28.13 info
Change: -$2.53 (-8%) info
Market Cap: $160.593B info